Notes
costs were expressed in 2010 Euros
Reference
Janzon M, et al. Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy. Heart : 16 Sep 2014. Available from: URL: http://doi.org/10.1136/heartjnl-2014-305864
Rights and permissions
About this article
Cite this article
Ticagrelor cost effective for ACS. PharmacoEcon Outcomes News 713, 24 (2014). https://doi.org/10.1007/s40274-014-1609-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1609-1